HOOK
Price
$0.77
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
9.33M
QURE
Price
$13.00
Change
+$3.61 (+38.45%)
Updated
Apr 17 closing price
Capitalization
703M
24 days until earnings call
Ad is loading...

HOOK vs QURE

Header iconHOOK vs QURE Comparison
Open Charts HOOK vs QUREBanner chart's image
HOOKIPA Pharma
Price$0.77
Change-$0.00 (-0.00%)
Volume$7.37K
Capitalization9.33M
uniQure
Price$13.00
Change+$3.61 (+38.45%)
Volume$14.46M
Capitalization703M
HOOK vs QURE Comparison Chart
Loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOOK vs. QURE commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOOK is a Hold and QURE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (HOOK: $0.77 vs. QURE: $13.00)
Brand notoriety: HOOK and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOOK: 14% vs. QURE: 1004%
Market capitalization -- HOOK: $9.33M vs. QURE: $703M
HOOK [@Biotechnology] is valued at $9.33M. QURE’s [@Biotechnology] market capitalization is $703M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOOK’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • HOOK’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, both HOOK and QURE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOOK’s TA Score shows that 5 TA indicator(s) are bullish while QURE’s TA Score has 5 bullish TA indicator(s).

  • HOOK’s TA Score: 5 bullish, 3 bearish.
  • QURE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HOOK is a better buy in the short-term than QURE.

Price Growth

HOOK (@Biotechnology) experienced а +4.50% price change this week, while QURE (@Biotechnology) price change was +51.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

HOOK is expected to report earnings on Nov 13, 2024.

QURE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($703M) has a higher market cap than HOOK($9.33M). QURE YTD gains are higher at: -26.387 vs. HOOK (-61.527). HOOK has higher annual earnings (EBITDA): -40.85M vs. QURE (-160.74M). QURE has more cash in the bank: 368M vs. HOOK (39.7M). HOOK has less debt than QURE: HOOK (875K) vs QURE (66.1M). HOOK has higher revenues than QURE: HOOK (43.9M) vs QURE (27.1M).
HOOKQUREHOOK / QURE
Capitalization9.33M703M1%
EBITDA-40.85M-160.74M25%
Gain YTD-61.527-26.387233%
P/E RatioN/AN/A-
Revenue43.9M27.1M162%
Total Cash39.7M368M11%
Total Debt875K66.1M1%
FUNDAMENTALS RATINGS
HOOK vs QURE: Fundamental Ratings
HOOK
QURE
OUTLOOK RATING
1..100
282
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9736
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOOK's Valuation (9) in the Pharmaceuticals Major industry is somewhat better than the same rating for QURE (74) in the Biotechnology industry. This means that HOOK’s stock grew somewhat faster than QURE’s over the last 12 months.

HOOK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as QURE (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to QURE’s over the last 12 months.

HOOK's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as QURE (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to QURE’s over the last 12 months.

QURE's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for HOOK (97) in the Pharmaceuticals Major industry. This means that QURE’s stock grew somewhat faster than HOOK’s over the last 12 months.

QURE's P/E Growth Rating (88) in the Biotechnology industry is in the same range as HOOK (100) in the Pharmaceuticals Major industry. This means that QURE’s stock grew similarly to HOOK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOOKQURE
RSI
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Ad is loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

HOOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOOK has been closely correlated with DARE. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOOK jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOOK
1D Price
Change %
HOOK100%
N/A
DARE - HOOK
87%
Closely correlated
-1.69%
CLNN - HOOK
86%
Closely correlated
-0.66%
PHIO - HOOK
81%
Closely correlated
+1.11%
AZTR - HOOK
81%
Closely correlated
-10.38%
IMRN - HOOK
79%
Closely correlated
+10.70%
More